GGZinGeest

The medical center is at the forefront of research in treatment resistant depression, focusing on innovative therapeutic approaches. The ongoing studies aim to evaluate the efficacy of novel treatments compared to traditional methods.

• Oral esketamine vs. Electroconvulsive Therapy (ECT)
• Long-term Maintenance Strategies

By exploring the potential of oral esketamine as a viable alternative to ECT, the center is contributing to the development of more accessible and less invasive treatment options for patients with non-psychotic therapy resistant depression.

Research at the center is pioneering new treatment possibilities for catatonia associated with various psychiatric conditions. The focus is on identifying effective interventions that can improve patient outcomes.

• Sodium Oxybate as a Treatment Option
• Impact on Depression, Bipolar Disorder, and Psychotic Disorders

The investigation into sodium oxybate as a potential treatment for catatonia is a significant step towards enhancing therapeutic strategies for complex psychiatric conditions, offering hope for improved management of this challenging symptom.